iTrack ab-interno canaloplasty significantly reduces medication dependency in POAG

Patients with controlled mild or moderate primary open-angle glaucoma also maintained IOP within the target range after the procedure

In this retrospective, single-center, case series, researchers included 35 patients (45 eyes) with controlled mild or moderate glaucoma (intraocular pressure ⩽17 mmHg). Mean baseline intraocular pressure was 14.42 ± 2.2 mmHg. Patients who had previously undergone glaucoma surgeries were excluded. iTrack ab-interno canaloplasty as a standalone procedure was done on 34 eyes and iTrack ab-interno canaloplasty in combination with cataract surgery was performed in 11 eyes.

At 36 months there was a significant decrease in the mean number of medications used (1.89 ± 0.93 versus 0.60 ± 0.82) and 56% of eyes were medication free. At 12 and 36 months, there was no significant difference in medication reduction when iTrack was used in combination or alone.

Baseline intraocular pressure was maintained at each follow-up visit (12, 24, and 36 months). There was no significant difference in IOP between the groups.

Reference
Khaimi MA. Long-term medication reduction in controlled glaucoma with iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery. Ther Adv Ophthalmol. 2021;13:25158414211045751. doi: 10.1177/25158414211045751. PMID: 34604698; PMCID: PMC8481718.